Robitussin-DAC Interactions
There are 646 drugs known to interact with Robitussin-DAC (codeine / guaifenesin / pseudoephedrine), along with 22 disease interactions, and 2 alcohol/food interactions. Of the total drug interactions, 132 are major, 509 are moderate, and 5 are minor.
- View all 646 medications that may interact with Robitussin-DAC
- View Robitussin-DAC alcohol/food interactions (2)
- View Robitussin-DAC disease interactions (22)
Most frequently checked interactions
View interaction reports for Robitussin-DAC (codeine / guaifenesin / pseudoephedrine) and the medicines listed below.
- acetaminophen
- Advicor (lovastatin / niacin)
- albuterol
- amitriptyline
- Aspirin Lite Coat (aspirin)
- Aspirin Low Strength (aspirin)
- Augmentin (amoxicillin / clavulanate)
- Avelox (moxifloxacin)
- Bayer Aspirin (aspirin)
- benzonatate
- Bromfed DM (brompheniramine / dextromethorphan / pseudoephedrine)
- carvedilol
- cefdinir
- cefprozil
- clarithromycin
- Claritin (loratadine)
- Claritin Reditabs (loratadine)
- clonazepam
- clotrimazole topical
- colchicine
- cyclobenzaprine
- Cymbalta (duloxetine)
- dexamethasone
- digoxin
- doxycycline
- Enablex (darifenacin)
- fluticasone nasal
- ibuprofen
- Mucinex DM (dextromethorphan / guaifenesin)
- prednisone
Robitussin-DAC alcohol/food interactions
There are 2 alcohol/food interactions with Robitussin-DAC (codeine / guaifenesin / pseudoephedrine).
Robitussin-DAC disease interactions
There are 22 disease interactions with Robitussin-DAC (codeine / guaifenesin / pseudoephedrine) which include:
- impaired GI motility
- infectious diarrhea
- prematurity
- acute alcohol intoxication
- drug dependence
- hypotension
- intracranial pressure
- respiratory depression
- gastrointestinal obstruction
- cardiovascular disease
- adrenal insufficiency
- liver disease
- renal dysfunction
- seizure disorders
- urinary retention
- arrhythmias
- biliary tract disease
- GI narrowing
- PKU
- BPH
- diabetes
- glaucoma
Report options
More about Robitussin-DAC (codeine / guaifenesin / pseudoephedrine)
- Compare alternatives
- Side effects
- Dosage information
- During pregnancy
- Drug class: upper respiratory combinations
Related treatment guides
Drug Interaction Classification
| Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
| Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
| Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
| No interaction information available. |
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.